Skip Navigation


European Heart Journal Advance Access originally published online on November 5, 2007
European Heart Journal 2007 28(23):2902-2908; doi:10.1093/eurheartj/ehm378
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
28/23/2902    most recent
ehm378v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Blomström-Lundqvist, C.
Right arrow Articles by Blomström, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomström-Lundqvist, C.
Right arrow Articles by Blomström, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. ©The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF)

Carina Blomström-Lundqvist1,*, Birgitta Johansson2, Eva Berglin3, Leif Nilsson4, Steen M. Jensen5, Stefan Thelin4, Anders Holmgren6, Nils Edvardsson2, Göran Källner7 and Per Blomström1

1 Department of Cardiology, Uppsala University Hospital, SE-75185 Uppsala, Sweden
2 Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
3 Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
4 Department of Cardiothoracic Surgery, Uppsala University Hospital, Uppsala, Sweden
5 Department of Cardiology, Umeå University Hospital, Umeå, Sweden
6 Department of Cardiothoracic Surgery, Umeå University Hospital, Umeå, Sweden
7 Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm, Sweden

Received 5 March 2007; revised 24 July 2007; accepted 10 August 2007; online publish-ahead-of-print 5 November 2007.

* Corresponding author. Tel: + 46 611 3113; fax: +46 18 510243. E-mail address: carina.blomstrom.lundqvist{at}akademiska.se

See page 2827 for the editorial comment on this article (doi:10.1093/eurheartj/ehm511)

Aims: The efficacy of epicardial left atrial (LA) cryoablation in eliminating atrial fibrillation (AF) in patients undergoing mitral valve surgery (MVS) is unknown. We hypothesized that MVS combined with LA cryoablation is superior to MVS alone.

Methods and results: Sixty-nine patients with permanent AF, included at four centres, underwent MVS with or without epicardial LA cryoablation. The primary endpoint was regained sinus rhythm. Risk factors for failed AF cryoablation were elucidated.

Sixty-five out of 69 patients reached the primary endpoint. At 6 and 12 months follow-up, 73.3% of patients who underwent cryoablation had regained sinus rhythm at both follow-ups, compared with 45.7 and 42.9% of patients, respectively, who underwent MVS alone (group differences, at 6 months P = 0.024, after 12 months P = 0.013). The in-hospital complication rate was 11.4% in the MVS group and 26.5% in the cryoablation group (P = 0.110). Risk factors for failed elimination of AF by cryoablation were duration of permanent AF (P = 0.012) and presence of coronary artery disease (P = 0.047), according to multiple logistic regression analysis.

Conclusion: This first prospective randomized study showed that combining MVS with epicardial LA cryoablation is significantly better in eliminating pre-operative permanent AF than MVS alone.

Key Words: Ablation • Fibrillation • Mitral valve


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation
Gerhard Hindricks and Hans Kottkamp
EHJ 2007 28: 2827-2829. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
G. Hindricks and H. Kottkamp
From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation
Eur. Heart J., December 1, 2007; 28(23): 2827 - 2829.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.